Skip to content

Eton Pharmaceutical

US · ETON #2944 by market cap Listed 2018
60.85 -0.51 -0.83%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Eton Pharmaceutical

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Founded
2017
Employees
44
Headquarters
Deer Park, Illinois, United States of America
Fiscal year end
12-31
Website
etonpharma.com

Company profile

Exchange
US
Symbol
ETON
Market-cap rank
#2944
Listing date
2018-11-09
Market cap
1.76B
Float cap
1.37B
Shares out
28.84M
Float shares
22.52M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 20:02:38 · For reference only, not investment advice and not tailored to your situation.

Eton Pharmaceutical discussion 0 comments

Add a comment